Michael Ullman, MD
Ophthalmology · Pensacola, FLNPI 1750776076
Payments from drug & device makers
What this record shows
This record is dominated by education: $1,200 of the $1,574 with a category attached, or 76.2%. Summit Surgical Corp. accounts for 76.2% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2021 at $1,200 and has fallen 95.7% since, to $52 in 2025. That places this record below the midpoint for ophthalmology clinicians in FL, where the typical reported total is $1,824.
Across 9 payments — averaging $174.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Summit Surgical Corp.$1K
- Mallinckrodt Hospital Products Inc.$123
- Bausch & Lomb Americas Inc.$110
- Carl Zeiss Meditec AG$39
- Rxsight Inc$32
- Regeneron Healthcare Solutions, Inc.$27
- plus $43 from 2 others
Across 1 payment — averaging $10,000 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Rxsight Inc$10K
What the payments were for
- Speaking & faculty fees$322%
- Food & beverage$30319%
- Education$1,20076%
- Gifts$392%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Summit Surgical Corp. | 1 | $1,200 |
| Mallinckrodt Hospital Products Inc. | 1 | $123 |
| Bausch & Lomb Americas Inc. | 1 | $110 |
| Carl Zeiss Meditec AG | 2 | $39 |
| Rxsight Inc | 1 | $32 |
| Regeneron Healthcare Solutions, Inc. | 1 | $27 |
| Aerie Pharmaceuticals, Inc. | 1 | $24 |
| Biotissue Holdings Inc. | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,574 in reported general payments places this provider in the 45th percentile of 1,405 ophthalmology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 805 | $39,368 |
| LumiganBimatoprost | 42 | $17,343 |
| Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol | 67 | $12,373 |
| CombiganBrimonidine Tartrate/Timolol | 33 | $10,736 |
| Latanoprost | 620 | $7,789 |
| Brimonidine Tartrate | 211 | $7,172 |
| Ofloxacin | 593 | $6,671 |
| Timolol Maleate | 509 | $6,648 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 243 | $4,429 |
| Brinzolamide | 15 | $2,584 |
| Dorzolamide-TimololDorzolamide/Timolol/Pf | 17 | $2,582 |
| ValacyclovirValacyclovir Hcl | 44 | $2,338 |
| Fluorometholone | 29 | $2,296 |
| Travoprost | 16 | $2,271 |
| Diclofenac Sodium | 168 | $1,941 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Pensacola
- Stephen JonesPensacola$202K
- Cathleen McCabeBradenton$2M
- Daniel KiernanSarasota$1.7M
- David EichenbaumSt Petersburg$1.7M
- Mark MilnerPalm Beach Gardens$1.2M
- Neel DesaiLargo$1M
- Jorge FortunPalm Beach Gardens$798K
- Courtney BoveeTampa$796K
- Harold BrooksTallahassee$683K
- Robert WeinstockLargo$605K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.